Kardi AI
Prague, CZ · Founded 2022 · 24 employees on LinkedIn · 3 known investors
Kardi Ai provides long-term heart rhythm monitoring through a wearable chest strap and AI-powered mobile application certified as a medical device under European regulations. The service is designed for consumers seeking preventive cardiac care and arrhythmia detection with physician-reviewed ECG analysis.
Also known as Kardi Ai
Investors · 3
Company profile
researched Aug 2026Kardi Ai offers a long-term cardiac rhythm monitoring service aimed at detecting heart arrhythmias and supporting prevention of stroke and heart failure outside of clinical settings. The service pairs an ECG recording device in the form of a chest strap with a mobile application that is certified as a medical device meeting European requirements. Users put on the chest strap and start a measurement from a smartphone; recordings can be taken at work, at home or during sport.
ECG recordings are evaluated automatically by artificial intelligence, with a processed result available to the user within about five minutes, and the application alerts the user when irregularities are found. The app also generates a detailed report on cardiac activity that can be provided to a physician, with the stated aim of supplying long-term data that routine examinations may not capture and that can inform personalised treatment and lifestyle recommendations. The application is available for iOS and Android.
Founding story
Czech cardiologist Prof. MUDr. Tomas Skala, Ph.D., FESC is described as a co-founder and comments on the clinical value of the long-term monitoring data the service produces.
Business model
Direct sale of the Kardi Ai monitoring service and chest strap hardware to end users via the company's website, with a companion mobile application; the site also invites enquiries from physicians' practices.
Product and service sales ordered online, promoted with discount codes (for example a 15% code during a sales wave) and delivery stated as within three days.
Traction
The company reports an average of 78 days of measurement and states that 37% of users uncovered an arrhythmia using Kardi Ai, alongside a counter of ECG measurements performed.
▸Full profile — market position, technology, go-to-market, geography
Market position
Positions itself as a pocket-sized long-term heart rhythm prevention and monitoring service that meets European medical device requirements, addressing arrhythmia that the company says affects over half a million people in the Czech Republic, 30% of whom are unaware of it.
Technology
ECG chest strap for signal recording linked to a smartphone application certified as a medical device under European requirements; AI-based automated analysis of ECG recordings delivering results within five minutes, automatic alerts on detected irregularities and generation of physician-facing reports.
Go-to-market
Consumer-facing online ordering with promotional discount campaigns, distribution of the app through Google Play and the Apple App Store, endorsement content from a cardiologist co-founder, and a contact form for individuals and medical practices.
Consumers interested in preventive cardiac care, including people with risk factors such as high blood pressure, high cholesterol, diabetes, obesity, smoking or family history, as well as physicians' practices.
Geography
Headquartered in Prague, Czech Republic, with a Czech-language consumer offering and messaging referencing cardiovascular disease and arrhythmia prevalence in the Czech Republic.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 1
primary sources listed
- Kardi AIkardi-ai.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Kardi AI do?
- Czech provider of long-term heart rhythm monitoring combining an ECG chest strap with a certified AI mobile app.
- Who are Kardi AI's investors?
- Kardi AI's investors include DEPO Ventures, Soulmates Ventures, BrightCap Investment Advisor AD.
- Where is Kardi AI headquartered?
- Kardi AI is headquartered in Prague, CZ.